The divergence between European STEMI guidelines and evidence: a potential threat to optimising reperfusion therapy for patients with ST-elevation myocardial infarction
Christian Juhl Terkelsen(MACOM (United States)), Eric Boersma(Erasmus MC), C. Michael Gibson(Baim Institute for Clinical Research), Evald Høj Christiansen(Aarhus University Hospital), Kjell Nikus(Tampere University Hospital), Hölger Thiele(Leipzig Heart Institute), Göran Olivecrona(Uppsala University), Goran Stanković(University of Belgrade), Hans-Henrik Tilsted Hansen(Aalborg University Hospital), Duane S. Pinto(Beth Israel Deaconess Medical Center), Jens Aarøe(Aalborg University Hospital), David Hildick‐Smith(Sussex County Community College), Georgios Sianos(Erasmus MC), Peter Clemmensen(Rigshospitalet), Jens Flensted Lassen(University of Southern Denmark), Anders Junker, Hans Erik Bøtker(Aarhus University)
Unknown
June 14, 2013
Cited by 14
Related Papers
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
|New England Journal of Medicine|2012|2.8k
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k